Analysis of the Dihydropyridine Receptor Site ofl-type Calcium Channels by Alanine-scanning Mutagenesis*

The dihydropyridine Ca2+antagonist drugs used in the therapy of cardiovacular disorders inhibitl-type Ca2+ channels by binding to a single high affinity site. Photoaffinity labeling and analysis of mutant Ca2+ channels implicate the IIIS6 and IVS6 segments in high affinity binding. The amino acid residues that are required for high affinity binding of dihydropyridine Ca2+ channel antagonists were probed by alanine-scanning mutagenesis of the α1C subunit, transient expression in mammalian cells, and analysis by measurements of ligand binding and block of Ba2+ currents through expressed Ca2+ channels. Eleven amino acid residues in transmembrane segments IIIS6 and IVS6 were identified whose mutation reduced the affinity for the Ca2+ antagonist PN200-110 by 2–25-fold. Both amino acid residues conserved among Ca2+ channels and those specific to l-type Ca2+ channels were found to be required for high affinity dihydropyridine binding. In addition, mutation F1462A increased the affinity for the dihydropyridine Ca2+ antagonist PN200-110 by 416-fold with no effect on the affinity for the Ca2+ agonist Bay K8644. The residues in transmembrane segments IIIS6 and IVS6 that are required for high affinity binding are primarily aligned on single faces of these two α helices, supporting a “domain interface model” of dihydropyridine binding and action in which the IIIS6 and IVS6 interact to form a high affinity dihydropyridine receptor site on l-type Ca2+ channels.

• Publication year

  1997

• Venue

  Journal of Biological Chemistry

• Publication date

  1997-07-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1074/jbc.272.30.18752PMID 9228048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Determinants of High Affinity Phenylalkylamine Block of l-type Calcium Channels in Transmembrane Segment IIIS6 and the Pore Region of the α1Subunit*

  1997cited by this paper
• Transfer of L-type Calcium Channel IVS6 Segment Increases Phenylalkylamine Sensitivity of (*)

  1996cited by this paper
• Two Amino Acid Residues in the IIIS5 Segment of L-Type Calcium Channels Differentially Contribute to 1,4-Dihydropyridine Sensitivity*

  1996cited by this paper
• Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha1A.

  1996cited by this paper
• Transfer of High Sensitivity for Benzothiazepines from L-type to Class A (BI) Calcium Channels*

  1996cited by this paper
• Molecular Determinants of High Affinity Dihydropyridine Binding in L-type Calcium Channels (*)

  1996cited by this paper
• Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.

  1996cited by this paper
• The IVS6 segment of the L‐type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.

  1996cited by this paper
• Calcium Binding in the Pore of L-type Calcium Channels Modulates High Affinity Dihydropyridine Binding (*)

  1995cited by this paper
• Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins.

  1995cited by this paper
• Dihydropyridines, phenylalkylamines and benzothiazepines block N-, P/Q- and R-type calcium currents

  1995cited by this paper
• Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit.

  1995cited by this paper
• Molecular Determinants of High Affinity Phenylalkylamine Block of L-type Calcium Channels (*)

  1995cited by this paper
• Toward a mechanism for the allosteric transition of pig kidney fructose-1,6-bisphosphatase.

  1994cited by this paper
• The naming of voltage-gated calcium channels.

  1994cited by this paper
• Auxiliary subunits of voltage-gated ion channels.

  1994cited by this paper
• Regulation and modulation of calcium channels in cardiac, skeletal, and smooth muscle cells.

  1994cited by this paper
• The naming of voltage-gated calcium channels

  1994cited by this paper
• Molecular basis for Ca2+ channel diversity.

  1994cited by this paper
• L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines.

  1994cited by this paper
• Auxiliary subunits of voltage-gated ion channels.

  1994cited by this paper
• Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels

  1993cited by this paper
• The benzazepine/benzothiazepine binding domain of the cardiac L-type Ca2+ channel is accessible only from the extracellular side

  1993cited by this paper
• Panning transfected cells for electrophysiological studies.

  1993cited by this paper
• Molecular localization of regions in the L-type calcium channel critical for dihydropyridine action.

  1993cited by this paper
• Structural basis of amino acid alpha helix propensity.

  1993cited by this paper
• Structure and functional expression of a member of the low voltage-activated calcium channel family.

  1993cited by this paper
• Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels.

  1993cited by this paper
• Identification of 1,4‐dihydropyridine binding domains within the primary structure of the α1 subunit of the skeletal muscle L‐type calcium channel

  1993cited by this paper
• Molecular cloning of the alpha-1 subunit of an omega-conotoxin-sensitive calcium channel.

  1992cited by this paper
• Structure and functional expression of alpha 1, alpha 2, and beta subunits of a novel human neuronal calcium channel subtype.

  1992cited by this paper
• Evidence for cooperative interactions in potassium channel gating

  1992cited by this paper
• Receptor sites for Ca2+ channel antagonists.

  1992cited by this paper
• Cloning of the alpha 1 subunit of a voltage-dependent calcium channel expressed in pancreatic beta cells.

  1992cited by this paper
• Structure and functional expression of α1, α2, and β subunits of a novel human neuronal calcium channel subtype

  1992cited by this paper
• Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine.

  1991cited by this paper
• Primary structure and functional expression from complementary DNA of a brain calcium channel

  1991cited by this paper
• Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium

  1991cited by this paper
• Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs.

  1991cited by this paper
• Distinct calcium channels are generated by alternative splicing and are differentially expressed in the mammalian CNS.

  1991cited by this paper
• Primary structure of a calcium channel that is highly expressed in the rat cerebellum.

  1991cited by this paper
• Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium‐channel alpha 1 subunit.

  1991cited by this paper
• Cloning and tissue-specific expression of the brain calcium channel beta-subunit.

  1991cited by this paper
• Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit.

  1991cited by this paper
• Cloning and tissue‐specific expression of the brain calcium channel β‐subunit

  1991cited by this paper
• Primary structure and functional expression from complementary DNA of a brain calcium channel.

  1991cited by this paper
• Escherichia coli aspartate transcarbamoylase: the molecular basis for a concerted allosteric transition.

  1990cited by this paper
• cDNA cloning of a dihydropyridine-sensitive calcium channel from rat aorta. Evidence for the existence of alternatively spliced forms.

  1990cited by this paper
• Influence of pHo on calcium channel block by amlodipine, a charged dihydropyridine compound. Implications for location of the dihydropyridine receptor

  1989cited by this paper
• The allosteric transition of glycogen phosphorylase

  1989cited by this paper
• Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel

  1989cited by this paper
• Identification and characterization of the dihydropyridine-binding subunit of the skeletal muscle dihydropyridine receptor.

  1987cited by this paper
• The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel.

  1987cited by this paper
• Subunit structure of dihydropyridine-sensitive calcium channels from skeletal muscle.

  1987cited by this paper
• Primary structure of the receptor for calcium channel blockers from skeletal muscle

  1987cited by this paper
• Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations.

  1987cited by this paper
• The effect of treatment with coenzyme Q10 on the mitochondrial function and superoxide radical formation in cardiac muscle hypertrophied by mild aortic stenosis.

  1987cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1987cited by this paper
• Photoaffinity labelling and phosphorylation of a 165 kilodalton peptide associated with dihydropyridine and phenylalkylamine-sensitive calcium channels.

  1987cited by this paper
• Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.

  1986cited by this paper
• Rapid and efficient site-specific mutagenesis without phenotypic selection.

  1985cited by this paper
• Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.

  1984cited by this paper
• Photoaffinity labelling of Ca2+ channels with [3H]azidopine

  1984cited by this paper
• Studies on voltage-operated calcium channels using radioligands.

  1983cited by this paper
• Does the organic calcium channel blocker D600 act from inside or outside on the cardiac cell membrane?

  1982cited by this paper

• Inhibition of CaV1.4 channels by CaV3 channel antagonists ML218 and Z944

  2025cites this paper
• Molecular, immunological, and physiological evidences of a sphingosine-activated plasma membrane Ca2+-channel in Trypanosoma equiperdum

  2024cites this paper
• Voltage gated sodium and calcium channels: Discovery, structure, function, and Pharmacology

  2023cites this paper
• Molecular Pharmacology of K2P Potassium Channels.

  2021cites this paper
• Structure and Pharmacology of Voltage-Gated Sodium and Calcium Channels.

  2020cites this paper
• Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-/T-type calcium channels.

  2019cites this paper
• Exploring The Calcium Channel Blocking Activity of 4-(2-Iodophenyl) 1,4-Dihydropyridine 3,5-Dicarboxylic Esters : Computational And Pharmacological Evaluation

  2019cites this paper
• Molecular Basis for Ligand Modulation of a Mammalian Voltage-Gated Ca2+ Channel.

  2019cites this paper
• Molecular Determinants of the Differential Modulation of Cav1.2 and Cav1.3 by Nifedipine and FPL 64176

  2018influential citation
• Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.

  2018cites this paper
• Combination of Photoaffinity Label and Site-Directed Antibody for Target Proteins

  2017cites this paper
• Photoaffinity Labeling for Structural Probing Within Protein

  2017cites this paper
• Coupling of excitation to Ca2+ release is modulated by dysferlin

  2017cites this paper
• Structure-function characterization of the human mitochondrial thiamin pyrophosphate transporter (hMTPPT; SLC25A19): Important roles for Ile(33), Ser(34), Asp(37), His(137) and Lys(291).

  2016cites this paper
• Molecular simulations study of novel 1,4‐dihydropyridines derivatives with a high selectivity for Cav3.1 calcium channel

  2015cites this paper
• Patch-Clamp and Voltage-Clamp Techniques

  2015cites this paper
• Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels

  2015cites this paper
• Developing T-type calcium channel blockers as potential therapies for pain.

  2014cites this paper
• New 5-unsubstituted dihydropyridines with improved CaV1.3 selectivity as potential neuroprotective agents against ischemic injury.

  2014cites this paper
• 1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain

  2014cites this paper
• Synthesis and Evaluation of 1,4-Dihydropyridine Derivatives with Calcium Channel Blocking Activity

  2013cites this paper
• Ca²⁺ channels and praziquantel: a view from the free world.

  2013cites this paper
• The Characterization of Nemadipine and Migrazole as Small Molecule Tools for Use in the Nematode Caenorhabditis elegans

  2013influential citation
• Harnessing Human N‐type Ca2+ Channel Receptor by Identifying the Atomic Hotspot Regions for Its Structure‐Based Blocker Design

  2012cites this paper
• Chapter 29 – Ion Channels as Targets for Drugs

  2012cites this paper
• Couplage entre les régions IIS4-S5 et IIS6 lors de l'activation du canal calcique CaV2.3

  2011cites this paper
• Mapping of dihydropyridine binding residues in a less sensitive invertebrate L-type calcium channel (LCav1)

  2011cites this paper
• A region of N-type Ca(2+) channel critical for blockade by the dihydropyridine amlodipine.

  2010cites this paper
• Estrogen-induced Signaling Links Structural and Functional Synaptic Plasticity

  2009cites this paper
• Differential sensitivities of CaV1.2 IIS5-S6 mutants to 1,4-dihydropyridine analogs.

  2009cites this paper
• Correction: A Genetic Screen for Dihydropyridine (DHP)-Resistant Worms Reveals New Residues Required for DHP-Blockage of Mammalian Calcium Channels

  2009cites this paper
• Mutations Leu427, Asn428, and Leu431 residues within transmembrane domain-I-segment 6 attenuate ginsenoside-mediated L-type Ca(2+) channel current inhibitions.

  2009cites this paper
• Structural Model for Dihydropyridine Binding to L-type Calcium Channels*

  2009cites this paper
• Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.

  2008cites this paper
• A Genetic Screen for Dihydropyridine (DHP)-Resistant Worms Reveals New Residues Required for DHP-Blockage of Mammalian Calcium Channels

  2008influential citation
• Cav1.2 Voltage-Gated Calcium Channel

  2008cites this paper
• BAY-K 8644

  2008cites this paper
• Estrogens directly potentiate neuronal L-type Ca2+ channels

  2008cites this paper
• Kv1.5 open channel block by the antiarrhythmic drug disopyramide: molecular determinants of block.

  2008cites this paper
• Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel: model construction and docking calculations.

  2007cites this paper
• Calcicludine binding to the outer pore of L-type calcium channels is allosterically coupled to dihydropyridine binding.

  2007cites this paper
• The Ca(v)2.3 voltage-gated calcium channel in epileptogenesis--shedding new light on an enigmatic channel.

  2006cites this paper
• Allosteric Interactions Required for High-Affinity Binding of Dihydropyridine Antagonists to CaV1.1 Channels Are Modulated by Calcium in the Pore

  2006cites this paper
• Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396.

  2006cites this paper
• The Molecular Basis of Ca2+ Antagonist Drug Action-Recent Developments

  2005cites this paper
• Functional Architecture of the Inner Pore of a Voltage-gated Ca2+ Channel

  2005influential citation
• Voltage-dependent calcium channels.

  2005cites this paper
• L-Type Calcium Channel Recording

  2005cites this paper
• International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels

  2005cites this paper
• Cav1.3 is preferentially coupled to glucose-induced [Ca2+]i oscillations in the pancreatic beta cell line INS-1.

  2004cites this paper
• Critical Amino Acid Residues in Transmembrane Domain 1 of the Human Organic Anion Transporter hOAT1*

  2004cites this paper
• Pharmacology of Cav1 (L-Type) Channels

  2004cites this paper
• Molecular Basis for Kv1.5 Channel Block

  2004cites this paper
• Opposite Effects of a Single IIIS5 Mutation on Phenylalkylamine and Dihydropyridine Interaction with L-type Ca2+ Channels*

  2004cites this paper
• Key Roles of Phe 1112 and Ser 1115 in the Pore-Forming IIIS5-S6 Linker of L-Type Ca 2 (cid:1) Channel (cid:1) 1C Subunit (Ca V 1.2) in Binding of Dihydropyridines and Action of Ca 2 (cid:1) Channel Agonists

  2003influential citation
• Molecular modeling of interactions of dihydropyridines and phenylalkylamines with the inner pore of the L-type Ca2+ channel.

  2003influential citation
• DHP‐insensitive L‐type‐like Ca channel of ascidian acquires sensitivity to DHP with single amino acid change in domain III P‐region

  2003cites this paper
• Molecular determinants of KCNQ1 channel block by a benzodiazepine.

  2003cites this paper
• Ca v 1.3 is preferentially coupled to glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1.

  2003cites this paper
• Identification and Functional Characterization of Voltage-dependent Calcium Channels in T Lymphocytes*

  2003cites this paper
• Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.

  2003cites this paper
• Cav1.3 Is Preferentially Coupled to Glucose-Stimulated Insulin Secretion in the Pancreatic β-Cell Line INS-1

  2003cites this paper
• Stereoselective Drug-Channel Interactions

  2003cites this paper
• The Role of Region IVS5 of the Human Cardiac Calcium Channel in Establishing Inactivated Channel Conformation

  2002cites this paper
• Molecular modelling of specific and non-specific anaesthetic interactions.

  2002cites this paper
• Regulation of Structural Plasticity by Different Channel Types in Rod and Cone Photoreceptors

  2002cites this paper
• Regionally selective alterations in expression of the alpha(1D) subunit (Ca(v)1.3) of L-type calcium channels in the hippocampus of aged rats.

  2002cites this paper
• Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel Block*

  2002cites this paper
• L-type Ca2+ channels in fetal and adult ovine cerebral arteries.

  2002cites this paper
• Inhibition of ATP-induced surfactant exocytosis by dihydropyridine (DHP) derivatives: a non-stereospecific, photoactivated effect and independent of L-type Ca2+ channels.

  2001cites this paper
• Homology model of dihydropyridine receptor: implications for L-type Ca(2+) channel modulation by agonists and antagonists.

  2001cites this paper
• Mechanism of Dihydropyridine Interaction with Critical Binding Residues of L-type Ca2+ Channel α1 Subunits*

  2001cites this paper
• An amino acid residue whose change by mutation affects drug binding to the HERG channel

  2001cites this paper
• Modeling of the outer vestibule and selectivity filter of the L-type Ca2+ channel.

  2001cites this paper
• State-dependent inhibition of L-type Ca2+ channels in A7r5 cells by cilnidipine and its derivatives.

  2001cites this paper
• Multiple structural elements contribute to voltage-dependent facilitation of neuronal alpha 1C (CaV1.2) L-type calcium channels.

  2001cites this paper
• Voltage‐dependent acceleration of Cav1.2 channel current decay by (+)‐ and (−)‐isradipine

  2001cites this paper
• Ion Channels as Targets for Drugs

  2001cites this paper
• Three-Dimensional Structure of the K+Channel Pore: Basis for Ion Selectivity and Permeability

  2001cites this paper
• Molecular Mechanism of Calcium Channel Block by Isradipine

  2000cites this paper
• Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.

  2000cites this paper
• A structural basis for drug-induced long QT syndrome.

  2000cites this paper
• State- and isoform-dependent interaction of isradipine with the α1C L-type calcium channel

  2000cites this paper
• Serine Residue in the IIIS5-S6 Linker of the L-type Ca2+ Channel α1C Subunit Is the Critical Determinant of the Action of Dihydropyridine Ca2+Channel Agonists*

  2000cites this paper
• Ca2+ channel antagonists and agonists

  2000cites this paper
• Structure of the Voltage-Dependent L-Type Calcium Channel

  2000cites this paper
• Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of L-type Ca(2+) channels.

  2000cites this paper
• Cardiac L‐Type Calcium Channel α1‐Subunit Is Increased by Cyclic Adenosine Monophosphate: Messenger RNA and Protein Expression in Intact Bone

  2000cites this paper
• Sequence differences between alpha1C and alpha1S Ca2+ channel subunits reveal structural determinants of a guarded and modulated benzothiazepine receptor.

  1999cites this paper
• Cloning of a calcium channel alpha1 subunit from the reef-building coral, Stylophora pistillata.

  1999cites this paper
• A Region in IVS5 of the Human Cardiac L-type Calcium Channel Is Required for the Use-dependent Block by Phenylalkylamines and Benzothiazepines*

  1999cites this paper
• Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels.

  1999cites this paper
• Stereoselective characterization of the 1,4-dihydropyridine binding site at L-type calcium channels in the resting state and the opened/inactivated state.

  1999cites this paper
• Sequence Differences between α1C and α1S Ca2+ Channel Subunits Reveal Structural Determinants of a Guarded and Modulated Benzothiazepine Receptor*

  1999cites this paper
• Voltage-dependent calcium channels: from structure to function.

  1999cites this paper
• Molecular Basis of Drug Interaction with L-Type Ca2+ Channels

  1998cites this paper
• Structural models of the transmembrane region of voltage-gated and other K+ channels in open, closed, and inactivated conformations.

  1998cites this paper
• Structural basis of drug binding to L Ca2+ channels.

  1998cites this paper
• Ca2+ channel block and inactivation: common molecular determinants.

  1998cites this paper
• Cloning and Functional Expression of a Voltage-gated Calcium Channel α1 Subunit from Jellyfish*

  1998cites this paper